Apeiron RIA’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Apeiron RIA’s Portfolio FBT Stock Details FBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,091	Closed	-$448K	–	210
2025 Q4	$448K	Sell	2,091 -28	-1%	-$5.59K	0.09%	127
2025 Q3	$390K	Buy	+2,119	New	+$361K	0.09%	141
2023 Q4	–	Sell	-1,424	Closed	-$208K	–	203
2023 Q3	$208K	Hold	1,424	–	–	0.07%	186
2023 Q2	$218K	Hold	1,424	–	–	0.07%	181
2023 Q1	$221K	Hold	1,424	–	–	0.08%	180
2022 Q4	$219K	Buy	+1,424	New	+$210K	0.08%	175
2022 Q2	–	Sell	-1,380	Closed	-$215K	–	159
2022 Q1	$215K	Buy	+1,380	New	+$204K	0.1%	142

Other funds holding FBT

First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

BFG

Berger Financial Group Plymouth, Minnesota $1.79B AUM 15.72% 1-Year Est. Return

Apeiron RIA's FBT Position: Q1 2026 in Review

Apeiron RIA sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q1 2026, closing a stake of 2,091 shares — an estimated $448K sold.

Apeiron RIA first reported a position in FBT in Q1 2022 and held it in 7 quarters. The position peaked at $448K in Q4 2025. 307 funds tracked by Wall St. Rank hold FBT as of Q1 2026.

Apeiron RIA reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q1 2026 after selling out during the quarter.
Apeiron RIA sold 2,091 First Trust NYSE Arca Biotechnology Index Fund shares in Q1 2026, an estimated $448K.
Apeiron RIA first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2022 and held it in 7 quarters.
Apeiron RIA's First Trust NYSE Arca Biotechnology Index Fund position peaked at $448K in Q4 2025.
307 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q1 2026.

Based on Apeiron RIA's 13F filing for Q1 2026, filed 27 Apr 2026.